Cheryl Guttman Krader
Sulzberger lecturer provides in-depth look at psoriasis comorbidities
In his talk at AAD 2017, Joel M. Gelfand, MD, MSCE, discussed the findings from research investigating associations between psoriasis and comorbidities and their relevance for providing comprehensive medical care for patients with psoriasis.
VMA associated with poor outcomes in anti-VEGF-treated patients
The presence of vitreomacular adhesion (VMA) is associated with poorer, short-term anatomic, and functional outcomes in eyes with diabetic macular edema (DME) receiving anti-VEGF therapy, according to Márcio B. Nehemy, MD, PhD.
End-stage glaucoma requires outside-of-the-box management
Although the aim of glaucoma management is to maintain visual function, the role of the ophthalmologist does not end once a patient has lost useful vision. Robert L. Stamper, MD, discussed care for patients with end-stage glaucoma.
Evolution in glaucoma surgery mounting with MIGS procedures
An expanding armamentarium of minimally invasive and micro-invasive glaucoma surgery procedures is transforming glaucoma management.
Home-monitoring devices offer better insight to figure out IOP
L. Jay Katz, MD. outlined the benefits of home IOP monitoring. These devices will offer a wealth of information that should lead to increased understanding of glaucoma and better patient care.
Micropulse probe transforms transscleral cyclophotocoagulation
Micropulse transscleral cyclophotocoagulation with a diode laser is demonstrating promising efficacy with better safety and tolerability than traditional TSCPC.
Novel drug delivery platforms: Filling a ‘GAP’ in glaucoma
Medical therapy for glaucoma is not becoming obsolete, but it is evolving away from conventional topical administration.
Multispecialty collaboration
Collaboration with specialists in other fields can improve outcomes for patients with skin cancer, and it can be personally and professionally rewarding for the dermatologist, according to one expert.
Building on cyclosporine for dry eye
A phase II study investigating a novel topical cyclosporine product (CyclASol, Novaliq) formulated in a semifluorinated alkane (SFA) vehicle showed promising efficacy, safety, and tolerability. Planning is ongoing for the phase III trial of cyclosporine in the SFA technology.
Teledermatology viable for skin cancer diagnosis
Teledermatology may play a role in skin cancer diagnsosis, an accumulating body of literature indicates, says one dermatologist.
var script= ' ';